Efanesoctocog alfa Clinical Trials
5 recruitingDrug
Phase 42Phase 11Phase 31
Showing 1–5 of 5 trials
Recruiting
Phase 3
Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa
Haemophilia A (Moderate or Severe)
Swedish Orphan Biovitrum104 enrolled24 locationsNCT06716814
Recruiting
Phase 4
Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa
Hemophilia A
Swedish Orphan Biovitrum250 enrolled27 locationsNCT06940830
Recruiting
Phase 1
Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A
Hemophilia A
Swedish Orphan Biovitrum24 enrolled8 locationsNCT06579144
Recruiting
Phase 4
Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
Factor VIII Deficiency
Sanofi35 enrolled13 locationsNCT06941870
Recruiting
A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan
Hemophilia A
Sanofi100 enrolled10 locationsNCT06684314